Hey biker , long time.
NPHC is stuck technically with faint squeals of fear but really its gearing up to be huge. New drug Nyloxin is prepared for launch with Cobroxin sales increases dramatically and doubling /tripling revenues. The companies operations are scaled up now 50%.
No Dilution from May onwards. While the O/S make numbers look small, there is the threat of a hostile takeover considering the future revenues this is adding up to. Also it is a bio tech.
I would watch this for a bottom.